Topics

Genetics of Ehlers-Danlos Syndrome

2017-03-28 23:38:22 | BioPortfolio

Summary

We are planning to collected blood and saliva for DNA extraction to use for genetic testing of children and adults with EDS and their relatives. Medical records from other institutions and clinical notes for visits in Dr. Holick's clinic will be reviewed to obtain the following information: previous diagnosis at other institutions, age, clinical signs and symptoms of EDS, Joints Hypermobility Syndrome (JHS), , and other metabolic or genetic disorders and laboratory results, radiology reports and images, and genetic testing that supports these diagnoses. Subjects' peripheral vein blood and saliva will be taken. No clinical intervention/randomizations will be performed. No patients' identifiers will be reported.

In this pilot study genomic DNA will be extracted and will be used for genotyping as sequencing in 30 EDS patients and their 30 relatives with or without EDS to compare genetic variations between them. After validation by Sanger sequencing for these variations, we plan to prepare a genetic panel for EDS. After all validation testing, we plan to evaluate the saliva DNA in a similar manner and compare the results with those obtained from the DNA from the blood sample. The purpose is that if they are comparable, we will be able to use saliva in place of blood as it easier method for accessing a person's DNA. This will be especially helpful for evaluating infants or those patients who prefer not to have a blood sample drawn.

Description

Ehlers-Danlos Syndrome (EDS) is a genetic disease that affects collagen synthesis and structure resulting in multisystem connective tissue involvement with twelve different subtypes. The clinical manifestations of EDS include skin hyperextensibility, skin fragility, joint hypermobility, muscle hypotonia, easy bruising, and mast cell hypersensitivity. We recently reported a cases series of EDS patients with different signs and symptoms. Most were evaluated along with their parents for evidence of acquired or inherited bone diseases. What is remarkable is that 93% of our cases at least one parent had clinically documented evidence for EDS a genetic disorder that compromises the structural integrity of the collagen/elastin matrix. Most of the parents were unaware they had this genetic disorder and the diagnosis was made for the first time in our clinic. Our previous study for reviewing patient's medical records was approved by the Boston University Medical Center's IRB. We have access to EDS patients from referrals and from Dr Holick's clinic. We plan to collect the blood and saliva samples from EDS patients and their relatives for this genetic study.

Genetic evaluation in limited number of our patients showed some causative variations. For example, one of our cases the patient was evaluated at an outside hospital for a causative variant in the COL5A1, COL5A2, FKBP14, and TNXB genes, which were negative, but she was found later to have a causative variant in serpin peptidase inhibitor, clade F, member 1 (SERPINF1) gene. A causative variation in SERPINF1 gene has been associated with osteogenesis imperfecta (OI) /EDS overlap syndrome and the mutation in this gene causes type VI OI.

The highly variable clinical presentation of patients with the hypermobility and clinical signs for EDS prompted an effort to classify patients with EDS into more homogeneous groups that can aid in diagnosis and management. This resulted in the establishment of 14 types (include 6 major types and 8 minor types). This classification acknowledges the presence of "others" including "unspecified" forms making it clear that the clinical and genetic heterogeneity of EDS could not be fully captured by that classification. Indeed, there have been numerous reports of patients with hereditary disorders of connective tissue, which have overlapping clinical manifestations of EDS, but do not meet the diagnostic criteria.

For decades, the genetic basis of heritable disorders of connective tissue had remained largely unknown. The rise of molecular genetics and its advances in next-generation sequencing has unlocked doors that continues to lead to major advances in understanding the causative genes for many genetic disorders.

Evaluation of subjects with these conditions often includes molecular testing which has important counseling, therapeutic and sometimes legal implications. An accurate molecular diagnosis can provide the basis for counseling regarding prognosis and reproductive options. Accurate genetic diagnosis has been shown to provide psychological benefits to patients and their families. In order to facilitate sequencing of multiple genes causing some of the common forms of these heritable conditions, we have designed this genetic study to obtain data for the genetic variations of EDS by next generation sequencing. The next generation sequencing panel may be of value in guiding future clinical pathways for genetic diagnosis in EDS. We plan to recruit EDS patients and their relatives for genetic testing. We also plan to submit a NIH grant for this purpose and provide required preliminary data through this pilot grant about genetic variation of EDS.

The primary objective is to compare genetic variations in EDS patients with their relatives. We expect to find some genetic variations that may explain clinical signs and symptoms in EDS patients.

Secondary objective is to provide a novel testing panel on a single diagnostic platform for EDS. After performing next generation sequencing, we plan to design a genetic panel for EDS.

A third objective will be to determine if saliva can be as good and reliable source of DNA for genetic testing as DNA obtained from blood.

Study Design

Conditions

Genetics Syndrome

Intervention

Genotyping

Status

Not yet recruiting

Source

Boston University

Results (where available)

View Results

Links

Published on BioPortfolio: 2017-03-28T23:38:22-0400

Clinical Trials [1169 Associated Clinical Trials listed on BioPortfolio]

Impact of Genotyping P450 2C19 on Hospitalization Period

Monocentric study with the objective to evaluate the impact of genotyping CYP2C19 on the hospitalization period. The genotyping will permit to adapt at best the Voriconazole posology.

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA

As an external validation test of the performance of the VeraCode Genotyping Test for Factor V and Factor II on the BeadXpress System, clinical trials will be conducted at three sites. Thi...

A Registry Study on Genetics and Biomarkers of Acute Coronary Syndrome

This is a national registry study to determine genetics risk factors and serial biomarkers of Acute Coronary Syndrome.

Life Quality Study for PFAPA Patient

This cohort study aims to assess the quality of life (or welfare) related to the health of children and adolescents with an non genetics auto-inflammatory disease PFAPA or Marshall syndrom...

PubMed Articles [7127 Associated PubMed Articles listed on BioPortfolio]

Genotyping based on complete coding sequences of porcine circovirus type 3 is stable and reliable.

Porcine circovirus type 3 (PCV3) is a newly identified virus, which is associated with PDNS-like clinical signs, reproductive failure, cardiac and multiorgan inflammation. However, the genotype of PCV...

A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder.

MAC-INMV-SSR: a web application dedicated to genotyping members of Mycobacterium avium complex (MAC) including Mycobacterium avium subsp. paratuberculosis strains.

Genotyping of Mycobacterium avium subsp. paratuberculosis (Map) is an indispensable tool for surveillance of this significant veterinary pathogen. For Map, multi-locus variable number tandem repeat an...

Aniridia and Axenfeld-Rieger Syndrome: Clinical presentations, molecular genetics and current/emerging therapies.

Aniridia and Axenfeld-Rieger Syndrome are related, human ocular disorders that are typically inherited in an autosomal dominant manner. Both result from incorrect development of the eye and have, as t...

De novo splice site variant of ARID1B associated with pathogenesis of Coffin-Siris syndrome.

Coffin-Siris syndrome is an extremely rare syndrome associated with developmental and congenital anomalies. It is caused by heterozygous pathogenic variants of ARID1A, ARID1B, SMARCA4, SMARCB1, SMARCE...

Medical and Biotech [MESH] Definitions

Methods used to determine individuals' specific ALLELES or SNPS (single nucleotide polymorphisms).

Methods for controlling genetic SEX of offspring. It may include SEX DETERMINATION (GENETICS) and other means.

A plant species of the family FABACEAE used to study GENETICS because it is DIPLOID, self fertile, has a small genome, and short generation time.

Condition with a variable constellation of phenotypes due to deletion polymorphisms at chromosome location 22q11. It encompasses several syndromes with overlapping abnormalities including the DIGEORGE SYNDROME, VELOCARDIOFACIAL SYNDROME, and CONOTRUNCAL AMOMALY FACE SYNDROME. In addition, variable developmental problems and schizoid features are also associated with this syndrome. (From BMC Med Genet. 2009 Feb 25;10:16) Not all deletions at 22q11 result in the 22q11deletion syndrome.

The process in developing sex- or gender-specific tissue, organ, or function after SEX DETERMINATION (GENETICS). Major areas of sex differentiation occur in the reproductive tract (GENITALIA) and the brain.

More From BioPortfolio on "Genetics of Ehlers-Danlos Syndrome"

Quick Search

Relevant Topics

DNA Extraction
DNA is extracted from human cells for a variety of reasons. With a pure sample of DNA you can test a newborn for a genetic disease, analyze forensic evidence, or study a gene involved in cancer. DNA isolation is a process of purification of DNA from...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Searches Linking to this Trial